| 000 | 01665 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250518073804.0 | ||
| 264 | 0 | _c20201106 | |
| 008 | 202011s 0 0 eng d | ||
| 022 | _a2376-1032 | ||
| 024 | 7 |
_a10.18553/jmcp.2019.19231 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBonafede, Machaon | |
| 245 | 0 | 0 |
_aAssessing the Association of Formulary Copayment Changes with Real-World Treatment Patterns in Patients with Rheumatoid Arthritis on Etanercept. _h[electronic resource] |
| 260 |
_bJournal of managed care & specialty pharmacy _cFeb 2020 |
||
| 300 |
_a211-220 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Observational Study | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aYoung Adult |
| 650 | 0 | 4 |
_aAntirheumatic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aArthritis, Rheumatoid _xdrug therapy |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 |
_aDeductibles and Coinsurance _xeconomics |
| 650 | 0 | 4 |
_aEtanercept _xadministration & dosage |
| 650 | 0 | 4 | _aFormularies as Topic |
| 650 | 0 | 4 | _aHealth Care Costs |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 |
_aTumor Necrosis Factor Inhibitors _xadministration & dosage |
| 700 | 1 | _aOko-Osi, Hafiz | |
| 700 | 1 | _aGharaibeh, Mahdi | |
| 700 | 1 | _aManjelievskaia, Janna | |
| 700 | 1 | _aLopez-Gonzalez, Lorena | |
| 700 | 1 | _aCollier, David H | |
| 700 | 1 | _aStolshek, Bradley S | |
| 773 | 0 |
_tJournal of managed care & specialty pharmacy _gvol. 26 _gno. 2 _gp. 211-220 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.18553/jmcp.2019.19231 _zAvailable from publisher's website |
| 999 |
_c30407462 _d30407462 |
||